My Beauty Spot Blemish Dots - Charcoal (10 patches)

Description

The product is identified as "my beauty spot blemish dots (charcoal)" and is packaged to contain 10 dots. Each dot is designed for targeted application to address blemishes.

Uses and Indications

This drug is indicated for the soothing and reduction of redness and irritation associated with blemished skin. It also serves to absorb excess oil, promoting faster healing of affected areas.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals are advised to instruct patients to begin by cleansing and drying the face thoroughly, ensuring that any makeup is completely removed. Following this, patients should apply one healing dot, ensuring the sticky side is placed directly over the blemish.

The healing dot should be left in place for a minimum of 6 hours, although overnight application is recommended for optimal results. Patients may repeat this process as necessary, using a new healing dot for each application.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid concurrent use of this product with other topical acne medications, as this may increase the risk of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to keep this product out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control center without delay.

Side Effects

Patients should be aware that this product is for external use only. When using this product, skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. In such cases, it is advised to limit the use to one topical acne medication at a time to minimize the risk of irritation.

Clinical experience suggests that the likelihood of skin irritation and dryness increases with concurrent use of multiple topical agents. Therefore, careful consideration should be given to the use of this product in conjunction with other acne treatments to ensure patient safety and comfort.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of My Beauty Spot Blemish Dots - Charcoal (10 patches) (salicylic acid 0.5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be informed of the uncertainties surrounding the use of this medication during pregnancy.

Lactation

There is no specific information regarding the use of MY BEAUTY SPOT BLEMISH DOTS - CHARCOAL in lactating mothers or its effects on breastfed infants. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this product.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the absence of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. It is crucial for healthcare professionals to consult relevant clinical guidelines and toxicology resources to determine the most appropriate management strategies.

In summary, while no specific overdosage information is available, vigilance and prompt intervention are paramount in managing potential overdose situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control center immediately. This precaution is vital to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in a package that should be stored in a cool, dry place to maintain its integrity. It is essential to keep the product out of reach of children to ensure safety. Once opened, the product must be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically. Patients should apply one healing dot, sticky side down, directly over the blemish. It is recommended to leave the healing dot in place for a minimum of 6 hours or overnight. Patients may repeat the application as necessary with a new healing dot.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for My Beauty Spot Blemish Dots - Charcoal (10 patches), including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)